Skip to main content
Caplight Logo









Biolytx Pharmaceuticals Corp.

Biolytx Pharmaceuticals Corp.

Private
Oklahoma City, OklahomaHealthcare & Life Scienceshttps://biolytx.com

Last Round

Seed

Nov 6, 2015

Total Funding Raised

$1.27M

Company Overview

Biolytx Pharmaceuticals Corp. is a biotechnology company developing a suite of antimicrobial peptide drug candidates for the treatment of serious pathogens with no current therapeutic options.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

peptide-based antibioticsantimicrobial peptidesantibiotic resistancesuperbugsdrug discoverypre-clinical drug developmentbiotech R&DCAP37 proteinhospital-acquired infectionsdrug resistant pathogenspharmaceutical licensingcystic fibrosis treatmenthospital-acquired pneumonia

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biolytx Pharmaceuticals Corp. Comparables

Compare Biolytx Pharmaceuticals Corp. with similar companies based on industry and business-model similarity.

Biolytx Pharmaceuticals Corp. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kinvard Bio
78%
Omnix Medical Ltd.
78%
Pfizer
76%

Biolytx Pharmaceuticals Corp. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 6, 2015

Biolytx Pharmaceuticals Corp. Investors

Notable investors and investment history

Biolytx Pharmaceuticals Corp. investors
InvestorRounds
i2ESeed
SeedStep AngelsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 6, 2015

    $1.1M round led by i2E.

Biolytx Pharmaceuticals Corp. Filings

Explore SEC and related filing metadata, where available.

Biolytx Pharmaceuticals Corp. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Biolytx Pharmaceuticals Corp.'s valuation, stock price, and market status.

Is Biolytx Pharmaceuticals Corp. a public or private company?

Biolytx Pharmaceuticals Corp. is a private company.

What is the current stock price of Biolytx Pharmaceuticals Corp.?

Biolytx Pharmaceuticals Corp. is a private company with no public stock price. No recent secondary market data is available.

How much is Biolytx Pharmaceuticals Corp. worth (valuation)?

Valuation information for Biolytx Pharmaceuticals Corp. is not publicly available.

Can I buy Biolytx Pharmaceuticals Corp. stock?

Biolytx Pharmaceuticals Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Biolytx Pharmaceuticals Corp.'s last funding round?

Funding round information for Biolytx Pharmaceuticals Corp. is not publicly available.

Who are the main investors in Biolytx Pharmaceuticals Corp.?

Investor information for Biolytx Pharmaceuticals Corp. is not publicly disclosed.

Will Biolytx Pharmaceuticals Corp. IPO soon?

No public IPO plans have been announced for Biolytx Pharmaceuticals Corp..

How can I track Biolytx Pharmaceuticals Corp. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biolytx Pharmaceuticals Corp.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOklahoma City, Oklahoma
Year Founded2005
Last FundingNov 6, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?